Calumet, Inc. (NASDAQ:CLMT) Given Consensus Rating of "Hold" by Analysts

Key Points

• Calumet has an average analyst recommendation of Hold from eight analysts (1 sell, 4 holds, 3 buys) with a one-year average price target of $30.50.
• Analysts are divided on the stock—HC Wainwright raised its target to $60 and kept a buy, while Goldman Sachs recently downgraded to neutral and other firms set mid‑$20s targets—reflecting mixed outlooks.
• Calumet beat quarterly EPS estimates (loss of $0.43 vs. est. loss $0.67) and reported revenue of $1.04B, up 9.4% year‑over‑year, though sell‑side consensus still forecasts a fiscal‑year EPS around -0.18.

Calumet, Inc. (NASDAQ:CLMT - Get Free Report) has been assigned an average recommendation of "Hold" from the eight analysts that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $30.50.

CLMT has been the topic of several research analyst reports. TD Cowen raised their price target on shares of Calumet from $19.00 to $25.00 and gave the stock a "hold" rating in a research report on Thursday, March 5th. UBS Group reaffirmed a "neutral" rating and set a $26.00 price objective on shares of Calumet in a report on Friday, February 13th. HC Wainwright raised their price objective on shares of Calumet from $33.00 to $60.00 and gave the stock a "buy" rating in a report on Monday, March 30th. Finally, The Goldman Sachs Group downgraded shares of Calumet from a "buy" rating to a "neutral" rating and set a $36.00 price objective for the company. in a report on Friday, April 24th.

Calumet Price Performance

NASDAQ CLMT opened at $32.53 on Thursday. The firm has a market capitalization of $2.82 billion, a price-to-earnings ratio of -83.41 and a beta of 0.86. The company's fifty day moving average is $30.98 and its two-hundred day moving average is $24.23. Calumet has a 52-week low of $10.14 and a 52-week high of $36.94.

Calumet (NASDAQ:CLMT - Get Free Report) last posted its quarterly earnings results on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.67) by $0.24. The company had revenue of $1.04 billion during the quarter, compared to analyst estimates of $1.04 billion. The business's revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.47) earnings per share. As a group, sell-side analysts expect that Calumet will post -0.18 earnings per share for the current fiscal year.

Insider Activity at Calumet

In other news, Director Daniel J. Sajkowski sold 3,310 shares of the firm's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $34.46, for a total transaction of $114,062.60. Following the completion of the transaction, the director directly owned 81,958 shares of the company's stock, valued at approximately $2,824,272.68. This trade represents a 3.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 4.07% of the company's stock.

Hedge Funds Weigh In On Calumet

A number of hedge funds and other institutional investors have recently made changes to their positions in CLMT. Islay Capital Management LLC bought a new position in shares of Calumet during the 4th quarter worth about $25,000. Aster Capital Management DIFC Ltd lifted its holdings in shares of Calumet by 294.7% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company's stock worth $33,000 after acquiring an additional 1,229 shares during the period. Global Retirement Partners LLC bought a new position in shares of Calumet during the 4th quarter worth about $34,000. Covestor Ltd lifted its holdings in shares of Calumet by 29.1% during the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company's stock worth $43,000 after acquiring an additional 492 shares during the period. Finally, State of Alaska Department of Revenue bought a new position in shares of Calumet during the 3rd quarter worth about $56,000. 34.41% of the stock is owned by institutional investors.

Calumet Company Profile

Calumet Specialty Products Partners, L.P. NASDAQ: CLMT is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet's product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.